BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21283681)

  • 1. Hepcidin is an antibacterial, stress-inducible peptide of the biliary system.
    Strnad P; Schwarz P; Rasenack MC; Kucukoglu O; Habib RI; Heuberger D; Ehehalt R; Müller MW; Stiehl A; Adler G; Kulaksiz H
    PLoS One; 2011 Jan; 6(1):e16454. PubMed ID: 21283681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.
    Zweers SJ; Shiryaev A; Komuta M; Vesterhus M; Hov JR; Perugorria MJ; de Waart DR; Chang JC; Tol S; Te Velde AA; de Jonge WJ; Banales JM; Roskams T; Beuers U; Karlsen TH; Jansen PL; Schaap FG
    Liver Int; 2016 Sep; 36(9):1370-7. PubMed ID: 26866350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
    Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
    Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiologic diagnosis of the gallbladder and bile ducts - part 2 : Acute and chronic cholecystitis, primary sclerosing cholangitis (PSC), benign and malignant masses of the biliary system].
    Helmberger H; Kammer B
    Radiologe; 2018 Dec; 58(12):1099-1114. PubMed ID: 30430195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
    Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
    J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.
    Reinhard L; Rupp C; Riedel HD; Ruppert T; Giese T; Flechtenmacher C; Weiss KH; Kloeters-Plachky P; Stremmel W; Schirmacher P; Sauer P; Gotthardt DN
    PLoS One; 2012; 7(1):e29821. PubMed ID: 22253789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium.
    Mandal A; Dasgupta A; Jeffers L; Squillante L; Hyder S; Reddy R; Schiff E; Das KM
    Gastroenterology; 1994 Jan; 106(1):185-92. PubMed ID: 7506217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling.
    Huang YH; Chuang JH; Yang YL; Huang CC; Wu CL; Chen CL
    Lab Invest; 2009 Oct; 89(10):1128-39. PubMed ID: 19652645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
    Pereira P; Aho V; Arola J; Boyd S; Jokelainen K; Paulin L; Auvinen P; Färkkilä M
    PLoS One; 2017; 12(8):e0182924. PubMed ID: 28796833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
    Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
    Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
    J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the bile microbiome in primary sclerosing cholangitis.
    Liwinski T; Zenouzi R; John C; Ehlken H; Rühlemann MC; Bang C; Groth S; Lieb W; Kantowski M; Andersen N; Schachschal G; Karlsen TH; Hov JR; Rösch T; Lohse AW; Heeren J; Franke A; Schramm C
    Gut; 2020 Apr; 69(4):665-672. PubMed ID: 31243055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of iron metabolism-regulator hepcidin in perinatal iron homeostasis].
    Balogh A; Bosze S; Horváti K; Mezo G; Kéki S; Nagy L; Bokodi G; Szabó M; Vásárhelyi B
    Orv Hetil; 2010 Jan; 151(3):83-91. PubMed ID: 20061265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prohepcidin binds to the HAMP promoter and autoregulates its own expression.
    Pandur E; Sipos K; Grama L; Nagy J; Poór VS; Sétáló G; Miseta A; Fekete Z
    Biochem J; 2013 Apr; 451(2):301-11. PubMed ID: 23390933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biliary HCO(3)(-) umbrella: experimental evidence revisited.
    Beuers U; Maroni L; Elferink RO
    Curr Opin Gastroenterol; 2012 May; 28(3):253-7. PubMed ID: 22450897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis.
    Kimura Y; Leung PS; Kenny TP; Van De Water J; Nishioka M; Giraud AS; Neuberger J; Benson G; Kaul R; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 2002 Nov; 36(5):1227-35. PubMed ID: 12395334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
    Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
    J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
    Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
    Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.